Safe Entry Stations
Mitigate risks to your team and to the uninterrupted operation of your business by setting up Safe Entry Stations for infectious disease symptom detection or for impairment detection. Our screening products for infectious disease and impairment are quick, noninvasive, no-contact solutions that can detect a first look indication of symptoms. All it takes is a simple walk-through.
Our Solutions
Our Partners
Our strategic partners help our team make a significant impact on the health and safety of people around the globe. We currently have partnerships in the US, Canada, and South Asia.










Accurate Detection Without Sacrificing Privacy
With multispectral cameras and sensors all functioning with full autonomy, you can screen quickly and easily all while maintaining privacy as a priority. Safe Entry Stations can also be customized for your location for permanent, temporary, and mobile use.

Recent Press
Predictmedix Provides Corporate Update on Key Technology Milestones and Commercialization Outlook for 2023
Toronto, Ontario, January 16, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced a corporate update providing key technology milestones and commercialization outlook for the 2023 calendar year. “Since the beginning of 2022, Safe Entry […]
Predictmedix Deploys Safe Entry’s Fit for Duty Screening at LongArm Engineering
LongArm Engineering to implement Safe Entry fitted with Fit for Duty Screening at Odessa Texas facility and new Corporate Office TORONTO, ON / ACCESSWIRE / November 17, 2022 / Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced the revenue-generating […]
Predictmedix Provides Business and Technology Development Updates and Closes Final Tranche of Private Placement
TORONTO, ON / Preedictmedix / November 7, 2022 / Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE:PMED)(OTCQB:PMEDF), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), announces that it has closed the final tranche of its non-brokered private placement. Pursuant to the final tranche, the Company has issued 1,600,000 units (the […]